Luxna Biotech Co., Ltd.
PrivateLast Round
Series C
Extension
Aug 7, 2025
Total Funding Raised
$20.26M
Momentum Score
25 /100
Company Overview
Luxna Biotech Co., Ltd. is a biotechnology company that develops oligonucleotide therapeutics based on modified nucleic acid technology licensed from Osaka University.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Luxna Biotech Co., Ltd. Comps
Public and private peers based on sector, stage, and business model.
Luxna Biotech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Aug 7, 2025 | ||||
| Series C | Sep 6, 2024 | ||||
| Series B | Dec 16, 2021 | ||||
| Series A | Feb 10, 2020 | ||||
| Seed | Mar 1, 2018 |
Luxna Biotech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kobe University Capital | Series C Extension |
| Shinsei Capital Partners | Series B |
| Mizuho Capital | Series B, Series A |
| Tohoku University Venture Partners | Series C |
| DCI Partners | Series C |
| 日本ベンチャーキャピタル株式会社 | Series B |
| Mitsubishi UFJ Capital | Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors increased 156% MoM, reaching 4.3K.
- Mar 16, 2026
Partnered with Inabata to expand GuNA amidite supply.
Luxna Biotech Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Luxna Biotech Co., Ltd.'s valuation, stock price, and market status.
